Growth hormone receptor could serve as possible target for improving lung cancer treatment

Researchers at Ohio University have discovered what may be a new way to fight lung cancer that is resistant to other ...
Drug Target Review

Blocking growth hormone may improve resistant lung cancer treatment

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
abc13

NFL, union agree to new drug policy, HGH testing

NEW YORK, NY -- The NFL finally will have HGH testing, perhaps as early as the end of this month. And of more immediate impact - this weekend - the new performance-enhancing drug policy the league and ...
Nasdaq

Ascendis Pharma's sBLA for TransCon hGH in Adult Growth Hormone Deficiency Accepted by FDA for Review

Ascendis Pharma's supplemental application for SKYTROFA in adult GHD has been accepted by the FDA, aiming for broader patient access. Acceptance of the sBLA does not guarantee approval; the company ...
Hosted on MSN

Ascendis Pharma’s Skytrofa gains FDA approval for growth hormone deficiency

The US Food and Drug Administration (FDA) has granted approval for Ascendis Pharma’s Skytrofa (lonapegsomatropin-tcgd, developed as TransCon hGH), a prodrug of somatropin or human growth hormone (HGH) ...
Nasdaq

FDA Accepts Ascendis Pharma’s Supplemental Biologics License Application for TransCon™ hGH for the Treatment of Adults with Growth Hormone Deficiency

COPENHAGEN, Denmark, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for review its supplemental ...
6abc News

NFL, union agree to new drug policy, HGH testing

NEW YORK -- The NFL reached an agreement with the players association on changes to its performance-enhancing drug policy, including the addition of human growth hormone testing, which will allow the ...